Cannabinoid modulation of neuronal function after oxygen/glucose deprivation in area CA1 of the rat hippocampus

Neuropharmacology

Volumn 52, Issue 6, 2007, Pages 1327-1335

  Youssef, Farid F ^a   Hormuzdi, Sheriar G ^b   Irving, Andrew J ^b   Frenguelli, Bruno G ^b  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Anoxic depolarisation; Cannabinoids; Endocannabinoids; Hypoxia; Ischemia; NMDA receptors; Oxygen glucose deprivation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BICUCULLINE; CANNABINOID RECEPTOR; DIZOCILPINE; ENDOCANNABINOID; GLUCOSE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXYGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPUS; HYPOGLYCEMIA; IN VITRO STUDY; MALE; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SYNAPTIC TRANSMISSION;

ANIMALS; BENZOXAZINES; CANNABINOIDS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; EXTRACELLULAR SPACE; FEMALE; GLUCOSE; HIPPOCAMPUS; HYPOXIA, BRAIN; MALE; MORPHOLINES; NAPHTHALENES; NEURONS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 34247401365     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.12.003     Document Type: Article

References (61)

1. Anderson W.W., and Collingridge G.L. The LTP program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Methods 108 (2001) 71-83
2. Baker D., Pryce G., Davies W.L., and Hiley C.R. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci. 27 (2006) 1-4
3. Begg M., Pacher P., Batkai S., Osei-Hyiaman D., Offertaler L., Mo F.M., Liu J., and Kunos G. Evidence for novel cannabinoid receptors. Pharmacol. Ther. 106 (2005) 133-145
4. Brown T.M., Brotchie J.M., and Fitzjohn S.M. Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake. J. Neurosci. 23 (2003) 11073-11077
5. Calabresi P., Centonze D., Pisani A., Cupini L., and Bernardi G. Synaptic plasticity in the ischaemic brain. Lancet Neurol. 2 (2003) 622-629
6. Chan G.C., Hinds T.R., Impey S., and Storm D.R. Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J. Neurosci. 18 (1998) 5322-5332
7. Chen Y., and Buck J. Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J. Pharmacol. Exp. Ther. 293 (2000) 807-812
8. Chen Y., McCarron R.M., Ohara Y., Bembry J., Azzam N., Lenz F.A., Shohami E., Mechoulam R., and Spatz M. Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ. Res. 87 (2000) 323-327
9. Coelho J.E., de M., and Ribeiro J.A. Presynaptic inhibitory receptors mediate the depression of synaptic transmission upon hypoxia in rat hippocampal slices. Brain Res. 869 (2000) 158-165
10. Collins D.R., Pertwee R.G., and Davies S.N. The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur. J. Pharmacol. 259 (1994) R7-R8
11. Crepel V., Epsztein J., and Ben Ari Y. Ischemia induces short- and long-term remodeling of synaptic activity in the hippocampus. J. Cell. Mol. Med. 7 (2003) 401-407
12. Dale N., Pearson T., and Frenguelli B.G. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol. 526 1 (2000) 143-155
13. 1 receptor in the mouse. Brain Res. 864 (2000) 186-194
14. 1 receptor in mice. Pharmacol. Biochem. Behav. 69 (2001) 251-259
15. 1 receptor. Neuroreport 12 (2001) 3973-3978
16. 1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons. Br. J. Pharmacol. 140 (2003) 547-557
17. Fairchild M.D., Parsons J.E., Wasterlain C.G., Rinaldi P.C., and Wallis R.A. A hypoxic injury potential in the hippocampal slice. Brain Res. 453 (1988) 357-361
18. Fowler J.C. Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus. Brain Res. 509 (1990) 331-334
19. Frenguelli B.G. The effects of metabolic stress on glutamate receptor-mediated depolarizations in the in vitro rat hippocampal slice. Neuropharmacology 36 (1997) 981-991
20. Gallily R., Breuer A., and Mechoulam R. 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. Eur. J. Pharmacol. 406 (2000) R5-R7
21. Grigg J.J., and Anderson E.G. Competitive and noncompetitive N-methyl-d-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison. J. Pharmacol. Exp. Ther. 253 (1990) 130-135
22. Guzman M., Sanchez C., and Galve R. Control of the cell survival/death decision by cannabinoids. J. Mol. Med. 78 (2001) 613-625
23. Hajos N., Katona I., Naiem S.S., Mackie K., Ledent C., Mody I., and Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12 (2000) 3239-3249
24. Hajos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
25. Hajos N., and Freund T.F. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids 121 (2002) 73-82
26. Hampson A.J., Bornheim L.M., Scanziani M., Yost C.S., Gray A.T., Hansen B.M., Leonoudakis D.J., and Bickler P.E. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J. Neurochem. 70 (1998) 671-676
27. Hampson A.J., Grimaldi M., Axelrod J., and Wink D. Cannabidiol and (-) Delta-9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 8268-8273
28. Hampson A.J., and Grimaldi M. Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. Eur. J. Neurosci. 13 (2001) 1529-1536
29. Hansen H.H., Schmid P.C., Bittigau P., Lastres B., Berrendero F., Manzanares J., Ikonomidou C., Schmid H.H., Fernandez R., and Hansen H.S. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J. Neurochem. 78 (2001) 1415-1427
30. Jourdain P., Nikonenko I., Alberi S., and Muller D. Remodeling of hippocampal synaptic networks by a brief anoxia-hypoglycemia. J. Neurosci. 22 (2002) 3108-3116
31. 1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21 (2001) 9506-9518
32. 1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 26 (2006) 2991-3001
33. Kim S.H., Won S.J., Mao X.O., Jin K., and Greenberg D.A. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury. J. Pharmacol. Exp. Ther. 313 (2005) 88-94
34. 1 receptor-independent action. Eur. J. Neurosci. 18 (2003) 1973-1978
35. Kofalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., and Sperlagh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25 (2005) 2874-2884
36. Lan R., Liu Q., Fan P., Lin S., Fernando S.R., McCallion D., Pertwee R., and Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42 (1999) 769-776
37. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568
38. de Mendonca A., and Ribeiro J.A. Contribution of metabotropic glutamate receptors to the depression of excitatory postsynaptic potentials during hypoxia. Neuroreport 8 (1997) 3667-3671
39. de Mendonca A., Sebastiao A.M., and Ribeiro J.A. Adenosine: does it have a neuroprotective role after all?. Brain Res. Brain Res. Rev. 33 (2000) 258-274
40. Misner D.L., and Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 19 (1999) 6795-6805
41. Monory K., Massa F., Egertova M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J.L., Goebbels S., Nave K.A., During M., Klugmann M., Wolfel B., Dodt H.U., Zieglgansberger W., Wotjak C.T., Mackie K., Elphick M.R., Marsicano G., and Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51 (2006) 455-466
42. 1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience 129 (2004) 743-750
43. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., and Greenberg D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 19 (1999) 2987-2995
44. 2+ signals in cerebellar granule neurons in culture. J. Neurosci. 19 (1999) 8765-8777
45. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., and Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci. 22 (2002) 3864-3872
46. Panikashvili D., Simeonidou C., Ben Shabat S., Hanus L., Breuer A., Mechoulam R., and Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413 (2001) 527-531
47. 1 cannabinoid receptor knock-out mice. J. Neurosci. 22 (2002) 9771-9775
48. Pearson T., Currie A.J., Etherington L.A., Gadalla A.E., Damian K., Llaudet E., Dale N., and Frenguelli B.G. Plasticity of purine release during cerebral ischemia: clinical implications?. J. Cell. Mol. Med. 7 (2003) 362-375
49. 1 receptors underlie the post-ischemic inhibition of neuronal function in rat hippocampus in vitro. J. Neurochem. 97 (2006) 1357-1368
50. Pegorini S., Zani A., Braida D., Guerini-Rocco C., and Sala M. Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection. Br. J. Pharmacol. 147 (2006) 552-559
51. Pringle A.K., Iannotti F., Wilde G.J., Chad J.E., Seeley P.J., and Sundstrom L.E. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res. 755 (1997) 36-46
52. + undershoots following brief anoxia in hippocampal slices. Brain Res. 402 (1987) 178-181
53. 1 receptors. Br. J. Pharmacol. 140 (2003) 1451-1459
54. Shouman B., Fontaine R.H., Baud O., Schwendimann L., Keller M., Spedding M., Lelievre V., and Gressens P. Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br. J. Pharmacol. 148 (2006) 442-451
55. Sinor A.D., Irvin S.M., and Greenberg D.A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci. Lett. 278 (2000) 157-160
56. van der Stelt M., Veldhuis W.B., Maccarrone M., Bar P.R., Nicolay K., Veldink G.A., Di M.V., and Vliegenthart J.F. Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol. Neurobiol. 26 (2002) 317-346
57. 1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139 3 (2006) 795-802
58. Tanaka E., Yamamoto S., Kudo Y., Mihara S., and Higashi H. Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. J. Neurophysiol. 78 (1997) 891-902
59. Tanaka E., Yasumoto S., Hattori G., Niiyama S., Matsuyama S., and Higashi H. Mechanisms underlying the depression of evoked fast EPSCs following in vitro ischemia in rat hippocampal CA1 neurons. J. Neurophysiol. 86 (2001) 1095-1103
60. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592
61. Zhu P.J., and Krnjevic K. Persistent block of CA1 synaptic function by prolonged hypoxia. Neuroscience 90 (1999) 759-770